OpenLegislation

Paragraph 2 Existing approvals of active substances, etc.: general

Original text. Later amendments are not shown.

(1)

An active substance, basic substance, low-risk active substance or candidate for substitution which is set out in an entry in a table in the Annex is deemed to have been approved by each competent authority in relation to its constituent territory under Article 13 of Regulation (EC) No 1107/2009 in accordance with sub-paragraphs 2(3) and 2(4).

(2)

Sub-paragraph (1) does not apply to the following entries in the table in Part A of the Annex—

(a)

entry 21 (Cyclanilide);

(b)

entry 33 (Cinidon-ethyl);

(c)

entry 43 (Ethoxysulfuron);

(d)

entry 45 (Oxadiargyl);

(e)

entry 49 (Cyfluthrin);

(f)

entry 56 (Mecoprop);

(g)

entry 72 (Molinate);

(h)

entry 87 (Ioxynil);

(i)

entry 94 (Imazosulfuron);

(j)

entry 100 (Tepraloxydim);

(k)

entry 113 (Maneb);

(l)

entry 120 (Warfarin);

(m)

entry 143 (Flusilazole);

(n)

entry 144 (Carbendazim);

(o)

entry 151 (Glufosinate);

(p)

entry 157 (Fipronil);

(q)

entry 159 (Spodoptera exigua nuclear polyhedrosis virus).

(3)

An active substance, basic substance, low-risk active substance or candidate for substitution to which sub-paragraph (1) applies is deemed to have been approved—

(a)

from the date of approval stated in the relevant entry in the Annex;

(b)

until the existing expiration date, except—

(i)

for a basic substance, or

(ii)

as provided for in sub-paragraph (4);

(c)

subject to the specific provisions stated in the relevant entry in the Annex as modified in accordance with paragraph 3.

(4)

Where the existing expiration date for an approval is 31st March 2022 or earlier, approval is taken instead to expire at the end of a period of three years beginning with the existing expiration date.

(5)

In this paragraph—

  • “the Annex” means the Annex to Commission Implementing Regulation (EU) No 540/2011 implementing Regulation (EC) No 1107/2009 of the European Parliament and of the Council as regards the list of approved active substances as it had effect immediately before exit day;

  • “existing expiration date” means the date for the expiration of approval stated in the relevant entry in the Annex.